These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 743012)

  • 1. Chronic hemofiltration. A critical evaluation of a new method for the treatment of blood.
    Schaefer K; von Herrath D; Gullberg CA; Asmus G; Hüfler M; Offermann G; Cremer H; Heuck CC; Ritz E
    Artif Organs; 1978 Nov; 2(4):386-94. PubMed ID: 743012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The beneficial effect of ketoacids on serum phosphate and parathyroid hormone in patients with chronic uremia.
    Schaefer K; von Herrath D; Asmus G; Umlauf E
    Clin Nephrol; 1988 Aug; 30(2):93-6. PubMed ID: 3180519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorbent recycling of ultrafiltrate in man--a 45-week crossover study.
    Shapiro WB; Schilb TP; Porush JG
    Clin Nephrol; 1986; 26 Suppl 1():S47-52. PubMed ID: 3829468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ways of intensification of hemodialysis therapy].
    Filiptsev PIa; Kirkhman VV; Timokhov VS
    Ter Arkh; 1988; 60(6):44-7. PubMed ID: 3206368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous hemofiltration/hemodialysis: an effective alternative to hemofiltration and conventional hemodialysis in the treatment of uremic patients.
    Leber HW; Wizemann V; Goubeaud G; Rawer P; Schütterle G
    Clin Nephrol; 1978 Mar; 9(3):115-21. PubMed ID: 639371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems and solutions for artificial kidney.
    Vanholder R
    Technol Health Care; 2000; 8(6):373-9. PubMed ID: 11258583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced treatment time: hemodialysis (HD) versus hemofiltration (HF).
    Keshaviah P; Berkseth R; Ilstrup K; McMichael C; Collins A
    Trans Am Soc Artif Intern Organs; 1985; 31():176-82. PubMed ID: 3837440
    [No Abstract]   [Full Text] [Related]  

  • 9. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A; Naderi AS
    Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemofiltration, an alternative method for treatment of end-stage renal failure.
    Man NK; Funck-Brentano JL
    Adv Nephrol Necker Hosp; 1977; 7():293-310. PubMed ID: 96676
    [No Abstract]   [Full Text] [Related]  

  • 11. [When is hemofiltration indicated, in the treatment of renal insufficiency? (author's transl)].
    Pogglitsch H
    Acta Med Austriaca; 1980; 7(4-5):144-7. PubMed ID: 7246019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RenaGel efficacy in severe secondary hyperparathyroidism.
    Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M
    Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Echocardiographic indices of uremia patients being treated by hemodiafiltration].
    Vinogradova TS; Filiptsev PIa; Kirkhman VV; Pronina VP; Timokhov VS
    Sov Med; 1988; (12):103-6. PubMed ID: 3242105
    [No Abstract]   [Full Text] [Related]  

  • 14. [Initial results in the treatment with short-term dialysis].
    Dogliani M; Jeantet A; Coppo R; Canavese C; Camussi G; Giacchino F; Pacitti A
    Minerva Med; 1976 Jul; 67(35):2282-8. PubMed ID: 951050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects and applications of hemofiltration.
    Weiss LG
    Scand J Urol Nephrol Suppl; 1989; 118():1-64. PubMed ID: 2785286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
    McGonigle RJ; Wallin JD; Husserl F; Deftos LJ; Rice JC; O'Neill WJ; Fisher JW
    J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialysis schedule and peripheral neuropathy.
    Cambi V; Svazzi G; Arisi L; Buzio C; Dall'Aglio P; Rossi E; Migone L
    Proc Eur Dial Transplant Assoc; 1973; 10(0):271-81. PubMed ID: 4369915
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluations of patients dialyzed with two Gambro four hours, three times per week.
    Mirahmadi KS; Kaye JH; Kastagir BK; Miller JH; Imparato B; Williams T; Gorman JT
    Proc Clin Dial Transplant Forum; 1973; 3():247-51. PubMed ID: 4806642
    [No Abstract]   [Full Text] [Related]  

  • 19. Continuous arteriovenous hemodialysis: an alternative therapy for acute renal failure associated with critical illness.
    Gibney RT; Stollery DE; Lefebvre RE; Sharun CJ; Chan P
    CMAJ; 1988 Nov; 139(9):861-6. PubMed ID: 3179891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Criteria of efficiency evaluation in periodic hemodialysis. Application of the square meter/hour hypothesis].
    Sanchez Sicilia L; Casajus S; Sanz Guajardo A; Alonso JL; Riñõn Aguilar MC; Almaráz Jiménez M
    Rev Clin Esp; 1974 Oct; 135(1):29-34. PubMed ID: 4457978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.